Attention-deficit/hyperactivity disorder (ADHD) is a bread-and-butter diagnosis in contemporary psychiatry. Most psychiatrists assess and treat it routinely, and adult diagnoses, in particular, have risen steadily. Yet the working model behind much of this practice rarely goes beyond the diagnostic label: a deficit of attention, a reduced capacity to focus, with or without hyperactivity.
The neuropsychological literature has not been kind to that model. Decades of experimental work have produced findings that are inconsistent across tasks, modest in magnitude, and difficult to reconcile with a simple shortfall in attentional capacity. As the evidence has accumulated, it has become less clear that attention is the primary deficit at all, and more plausible that the attentional symptoms clinicians observe are downstream of a different underlying problem. How we answer this question shapes how we assess patients and how we explain the condition to the people who have it.
This article, the first of three, takes stock of the expert consensus on what ADHD is and where leading researchers see that understanding shifting.
Reference Points for Discussion
Three recent documents are useful anchors for our purposes here.
The World Federation of ADHD International Consensus Statement (2021) distilled 208 conclusions from meta-analyses and large registry studies. It concludes that ADHD, diagnosed by a clinician, is supported by validators and is a clinically useful category in all age groups. It is highly heritable (based on twin studies) and responds well to treatment. However, neither neuropsychological tests nor neuroimaging can diagnose ADHD, and diagnosis rests on clinical assessment.
The 2023 Annual Research Review by Sonuga-Barke and colleagues takes a different tack. It argues that the taxonic model of ADHD as a singular, categorical, neurodevelopmental entity caused by dysfunction within the individual has been strained by accumulated evidence.
Most recently, the October 2025 World Psychiatry Forum brought together international experts with multiple invited commentaries. The review affirms the descriptive, predictive, and concurrent validity of adult ADHD. It also identifies live controversies, such as ADHD with late onset, emotional dysregulation as a core feature, the role of executive dysfunction, objective diagnostic measures, long-term treatment effects, and the place of nonpharmacologic treatment.
These documents by and large defend the utility of the diagnosis while acknowledging that our model of what ADHD refers to is incomplete.
‘Deficit’ to ‘Dysregulation’: What Is Attention’?
“Attention” means different things in the clinic and in the cognitive neuroscience laboratory. In the lab, it usually means selective amplification of relevant information, such as shifting processing resources to a location in space, or following one conversation in a crowded room. These capacities are tied to the dorsal and ventral attention networks and the frontoparietal network. The classic “inattention” of ADHD criteria is something else: not staying on task, being sidetracked, forgetting instructions, avoiding effortful tasks. As neuroscientist Michael Halassa has noted, these are problems of sustained engagement, not selective processing.
The World Psychiatry review makes a related point. Motivation and task relevance shape symptom expression, and “hyperfocus” in highly rewarding activities is common, so ADHD “can thus be viewed as an attention dysregulation (rather than deficit) disorder.” Many patients can concentrate. What they cannot do is deploy concentration on demand, at the ordinary moments when it is needed.
Researchers, such as Sonuga-Barke, have argued that the behaviors included in the ADHD diagnosis can arise by several distinct routes, such as problems in behavioral inhibition, delay aversion, and disruptions in temporal tracking. Neuropsychological heterogeneity is now the consensus view. Executive dysfunction is present at the group level, but group differences on neuropsychological tests are much smaller than differences in symptoms, and many individuals show no deficits. Coghill notes that fewer than half of people with ADHD perform poorly on formal executive function tests. Rating-scale measures of everyday executive difficulty, such as the BRIEF, correlate strongly with ADHD symptoms but weakly with executive function tests. In other words, “executive function” measured in daily life and in the laboratory are not the same construct. That is the same gap we see with “attention.”
This bears on a live question: Should executive function be a core feature of ADHD? Executive manifestations, such as trouble prioritizing and finishing tasks on time, are among the strongest predictors of an adult diagnosis. Coghill nevertheless argues that executive difficulties are better treated as an associated feature than a core one. Laboratory tasks are brief, novel, and supervised, which are exactly the conditions under which ADHD symptoms tend to normalize and is why neuropsychological research on executive functioning in laboratory settings produces mixed results.
Dimensional, Fluctuating, Broader Phenotype
Twin heritability of ADHD is about 74% and does not increase with severity, which implies that ADHD is the extreme end of a continuous trait. Taxometric research supports dimensions over categories, and there is no discrete impairment threshold. The World Psychiatry authors state plainly that any clinical cutoff involves a degree of arbitrariness.
ADHD is not the static condition once assumed. In the Multimodal Treatment Study of ADHD, about 60% of remitters experienced recurrence after an initial remission. Symptoms wax and wane with environmental demands. Most children with ADHD no longer meet full criteria by age 30, yet about 70% still have symptoms and about 65% have functional impairment. Adult prevalence is about 2.5%, declining to roughly 1% by age 60.
In the broader phenotype, several features sit at the edge of the current construct:
- Emotion dysregulation affects close to half of individuals with ADHD. It was central to the earliest descriptions of adult ADHD. Its interpretation is contested. It may be a core feature, a legacy of unrecognized childhood oppositional defiant disorder, or, in some presentations, part of a bipolar spectrum. Brief anger outbursts with rapid return to baseline are read differently by different clinicians. Reif notes that ADHD with depression often shows features of mood disorder and a higher risk for treatment-resistant depression.
- Cognitive disengagement syndrome, formerly called “sluggish cognitive tempo,” involves daydreaming, mental fogginess, and slowness. A 2023 work group adopted the new name, and it is increasingly seen as a transdiagnostic specifier.
- Sleep and circadian disturbance are pervasive. Kooij reports that sleep loss affects about 80% of children and adults with ADHD before any stimulant exposure. Delayed sleep phase is the most common comorbid sleep disorder, and evening melatonin onset is delayed by about 1.5 hours in adults with ADHD.
- Impulsivity is undermeasured. The DSM-5 has only three impulsivity items, while multidimensional measures show adults with ADHD are elevated on negative and positive urgency, lack of premeditation, and lack of perseverance. The apparent decline of impulsivity with age may partly be a measurement artifact.
Rethinking the Construct
Expert consensus has established that a DSM diagnosis of ADHD is supported by validators, associated with impairment, and treatable in children and adults, but it is neither a discrete disease entity nor explained by central neuropsychological or neurobiological abnormalities. The scientific frontier suggests our model of what it is still needs revision. ADHD looks less like a neuropsychological deficit of attention and more like a heterogeneous, dimensional, fluctuating dysregulation of focus. The problem is not simply an inability to attend. It extends across a range of domains, such as difficulty deploying and sustaining attention and effort when tasks hold little intrinsic value, intertwined with problems of behavioral control, motivation, and arousal. Clinicians should also expect presentations to vary considerably from one patient to the next, and within the same patient over time.
The author used generative AI assistance (Anthropic Claude Opus 5.5) during the writing process. While the core arguments, analysis, and substantive points were entirely conceived and drafted by the author, the AI was utilized to organize detailed bullet points and partial drafts into continuous prose. The final manuscript was thoroughly reviewed, revised, and edited by the author, who takes full responsibility for its content, wording, and accuracy.
Awais Aftab, MD, is a clinical associate professor of psychiatry at Case Western Reserve University in Cleveland, Ohio. His work focuses on conceptual and critical issues in psychiatry, psychopharmacology, and psychiatric diagnosis. He is the author of Conversations in Critical Psychiatry (Oxford University Press, 2024) and writes the Substack newsletter Psychiatry at the Margins. His research and commentary have appeared in leading psychiatric journals and publications, including JAMA Psychiatry, The American Journal of Psychiatry, World Psychiatry, and The New York Times.
https://www.medscape.com/viewarticle/what-adhd-why-attention-deficit-model-falls-short-2026a10017ik

No comments:
Post a Comment
Note: Only a member of this blog may post a comment.